Finance

Beta
Lists
KBLB:OTCMKTS
Kraig Biocraft Laboratories Inc
$0.12
+0.84%
(+0.00100) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KBLB...
Open
$0.12
High
$0.12
Low
$0.12
Mkt. cap
132.45M
Avg. vol.
1.16M
Volume
393.72K
52-wk high
$0.16
52-wk low
$0.07
EPS
-$0.00
Beta
1.48
Shares outstanding
1.11B
No. of employees
41
Open
$0.12
High
$0.12
Low
$0.12
Mkt. cap
132.45M
Avg. vol.
1.16M
Volume
393.72K
52-wk high
$0.16
52-wk low
$0.07
EPS
-$0.00
Beta
1.48
Shares outstanding
1.11B
No. of employees
41
News stories
From sources across the web
Profile
Kraig Biocraft Laboratories, Inc. is an American biotechnology company headquartered in Ann Arbor, Michigan. It develops and manufactures recombinant spider silks and other high-performance polymers using spider silk gene sequences. Their most notable fiber is dragon silk which has been demonstrated to be tougher than many fibers used in bullet proof vests. Wikipedia
About Kraig Biocraft Laboratories Inc
CEO-
Employees41
Founded2006
HeadquartersAnn Arbor, Michigan, United States
SectorCommodity chemical
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
63.89K
9.24K
68.75K
66.70K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
573.86K
1.42M
653.92K
758.80K
Operating expense
637.74K
1.43M
722.67K
825.50K
Total operating expenses
637.74K
1.43M
722.67K
825.50K
Operating income
-637.74K
-1.43M
-722.67K
-825.50K
Other non operating income
-
-
-
-
EBT including unusual items
-726.13K
-1.51M
-787.62K
-942.72K
EBT excluding unusual items
-778.59K
-1.58M
-860.85K
-963.13K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-726.13K
-1.51M
-787.62K
-942.72K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
1.14K
1.12K
5.94K
10.80K
Interest expense
-141.99K
-144.26K
-144.12K
-148.43K
Net interest expenses
-140.85K
-143.14K
-138.18K
-137.63K
Depreciation and amortization charges
-
-
-
-
EBITDA
-631.91K
-1.43M
-715.07K
-819.28K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more